Study of serum hepcidin level and its relation to recombinant human erythropoietin resistence, markers of iron status and C-reactive protein in patients with end stage renal disease on maintenance hemodialysis.
Elbadawy, A., Ibraheim, W., Khalil, M., Elhawary, O., Abdelmoneim, R. (2021). Study of serum hepcidin level and its relation to recombinant human erythropoietin resistence, markers of iron status and C-reactive protein in patients with end stage renal disease on maintenance hemodialysis.. EKB Journal Management System, 38(2), 497-510. doi: 10.21608/bmfj.2021.66540.1391
Ayman Elbadawy; W. M. Ibraheim; Medhat Khalil; omar Elhawary; Rasha Abdelmoneim. "Study of serum hepcidin level and its relation to recombinant human erythropoietin resistence, markers of iron status and C-reactive protein in patients with end stage renal disease on maintenance hemodialysis.". EKB Journal Management System, 38, 2, 2021, 497-510. doi: 10.21608/bmfj.2021.66540.1391
Elbadawy, A., Ibraheim, W., Khalil, M., Elhawary, O., Abdelmoneim, R. (2021). 'Study of serum hepcidin level and its relation to recombinant human erythropoietin resistence, markers of iron status and C-reactive protein in patients with end stage renal disease on maintenance hemodialysis.', EKB Journal Management System, 38(2), pp. 497-510. doi: 10.21608/bmfj.2021.66540.1391
Elbadawy, A., Ibraheim, W., Khalil, M., Elhawary, O., Abdelmoneim, R. Study of serum hepcidin level and its relation to recombinant human erythropoietin resistence, markers of iron status and C-reactive protein in patients with end stage renal disease on maintenance hemodialysis.. EKB Journal Management System, 2021; 38(2): 497-510. doi: 10.21608/bmfj.2021.66540.1391